The Daedalus Fund for Innovation is a program designed to foster, advance and build value around promising early-stage translational research projects and emerging technologies that have commercial potential. Established in 2014, the Daedalus Fund helps our investigators to bridge and overcome the “development gap,” enhancing their research projects and enabling Weill Cornell Medicine to offer the industry more compelling, investment-grade opportunities for business development.
Professor of Pathology and Laboratory Medicine
On November 30th, the 2nd annual Daedalus Fund for Innovation Awards Reception was held at the Belfer Research Building. Featuring keynote speaker Dr. George Yancopoulos, president and chief scientific officer at Regeneron Laboratories, the event also highlighted this year’s four award recipients:
Shahin Rafii, MD Director, Ansary Stem Cell Institute
Juan Cubillos-Ruiz, PhD Assistant Professor of Microbology and Immunology
Theodore Schwartz, MD David and Ursel Barnes Professor of Minimally Invasive Neurosurgery, Professor of Neuroscience, Neurological Surgery and Neurological Surgery in Otolaryngology
Pengbo Zhou, PhD Professor of Pathology and Laboratory Medicine
Source: Milestones, March 2016